Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Frontiers in Oncology
Karam KhaddourYanis Boumber

Abstract

Body composition refers to the proportional content of body fat mass and lean body mass that can lead to a continuum of different phenotypes ranging from cachectic/sarcopenic state to obesity. The heterogenetic phenotypes of body composition can contribute to formation of some cancer types and can sometimes lead to disparate outcomes. Both of these extremes of the spectrum exist in patients with non-small cell lung carcinoma (NSCLC). The discovery of new pathways that drive tumorigenesis contributing to cancer progression and resistance have expanded our understanding of cancer biology leading to development of new targeted therapies including tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICI) that have changed the landscape of NSCLC treatment. However, in the new era of precision medicine, the impact of body composition phenotypes on treatment outcomes and survival is now being elucidated. In this review, we will discuss the emerging evidence of a link between body composition and outcomes in patients with NSCLC treated with TKI and ICI. We will also discuss suggested mechanisms by which body composition can impact tumor behavior and anti-tumor immunological response.

References

Jul 16, 1987·Nature·J F BrunetP Golstein
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jul 1, 1997·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·H ShimizuM Mori
Mar 8, 2000·The Journal of Experimental Medicine·M K KennedyJ J Peschon
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Edward Y WooCarl H June
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Nov 9, 2004·Trends in Immunology·Lorenzo MorettaAlessandro Moretta
Mar 4, 2005·The International Journal of Biochemistry & Cell Biology·Josep M ArgilésFrancisco J López-Soriano
Jun 27, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Marcello MaggioLuigi Ferrucci
Apr 11, 2007·Circulation·Fahad RazakSalim Yusuf
Aug 11, 2007·The Journal of Physiology·Anders Rinnov NielsenBente Klarlund Pedersen
Feb 20, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A Romero-CorralF Lopez-Jimenez
Oct 17, 2008·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Marina MourtzakisVickie E Baracos
Jul 9, 2009·International Journal of Cancer. Journal International Du Cancer·Ling YangZhengming Chen
Apr 1, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tomoya KawaguchiSai-Hong Ignatius Ou
Jun 28, 2011·The Journal of Surgical Research·Relin YangTeresa A Zimmers
Jul 30, 2011·Skeletal Muscle·Tyesha N Burks, Ronald D Cohn
Aug 9, 2011·Annals of Surgical Oncology·Michael S SabelStewart Wang
Feb 23, 2013·Medical Oncology·Theodora KerenidiKonstantinos I Gourgoulianis
Mar 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa MartinVickie E Baracos
Jul 28, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Suzanne E DahlbergDavid H Johnson
Dec 11, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jonathan M HanMegan K Levings
Feb 8, 2014·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Mark K FergusonWickii T Vigneswaran
Feb 25, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Miroslav KovarikZdenek Zadak
Feb 28, 2014·The American Journal of Clinical Nutrition·Maria Cristina GonzalezSteven B Heymsfield
Apr 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D S M ChanT Norat
Oct 14, 2014·Frontiers in Immunology·Michael James KraakmanHélène L Kammoun
Nov 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin C ConlonThomas A Waldmann
Dec 4, 2014·Molecular and Clinical Oncology·Tomohiro TamuraNobuyuki Hizawa
May 7, 2015·Expert Opinion on Pharmacotherapy·Hongjie Zhang, Jose M Garcia
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Aug 19, 2015·Current Cancer Drug Targets·Saїd C AzouryVivek Shukla

❮ Previous
Next ❯

Software Mentioned

Tomovision
SliceOmatic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.